Order Article Reprints

Kovaleva A, Poluektova E, Maslennikov R, Karchevskaya A, Shifrin O, Kiryukhin A, Tertychnyy A, Kovalev L, Kovaleva M, Lobanova O, et al. Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial. Journal of Clinical Medicine. 2023; 12(18):6064. https://doi.org/10.3390/jcm12186064

Kovaleva, Aleksandra, Elena Poluektova, Roman Maslennikov, Anna Karchevskaya, Oleg Shifrin, Andrey Kiryukhin, Aleksandr Tertychnyy, Leonid Kovalev, Marina Kovaleva, Olga Lobanova, and et al. 2023. "Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial" Journal of Clinical Medicine 12, no. 18: 6064. https://doi.org/10.3390/jcm12186064

Kovaleva, A., Poluektova, E., Maslennikov, R., Karchevskaya, A., Shifrin, O., Kiryukhin, A., Tertychnyy, A., Kovalev, L., Kovaleva, M., Lobanova, O., Kudryavtseva, A., Krasnov, G., Fedorova, M., & Ivashkin, V. (2023). Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial. Journal of Clinical Medicine, 12(18), 6064. https://doi.org/10.3390/jcm12186064